FDA Investigator Anissa M Vargas

Anissa M Vargas has inspections in 10 countries as of 12 May 2023. Anissa M Vargas has collaborated with a combinined 2353 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
22
Last Inspection Date:
12 May 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
Canada, Germany, Singapore, United States of America, Netherlands, Switzerland, France, Mexico, China, Argentina
Co-Investigator(s):
Alice S Tsao, Amanda L Fyles, Ana P Pineda Zavaleta, Anita Narula, PhD, Anita R Michael, Anna Lazar, Anthony A Charity, Ariel Cruz Figueroa, Arnold Seo, PhD, Arsen Karapetyan, Ashar P Parikh, Azza Talaat, Barbara J Rincon, Brian D Nicholson, Camerson E Moore, Carrie A Hughes, CDR Thomas R Berry, PPh, Charisse K Green, Charles M Edwards, Chiang Syin, PhD, Christopher R Czajka, Concepcion Cruz, Jr, Crystal Monroy, Dale A Nyberg, David M Beltran, Dell S Moller, Demitria J Argiropoulos, Demitria J Xiradakis, Donna F Campbell, Douglas C Kovacs, Dr. Carmelo Rosa, Edwin Melendez, Eric L Dong, BS, Eric M Mueller, PharmD, Erika V Butler, Felix Maldonado, George Lunn, PhD, German Rivera, Gregson A Joseph, Hamet Toure, PharmD MPH, Helen B Ricalde, Heriberto Negron Rivera, Ivan E Reyes, Jacqueline S Warner, James A Liubicich, James C Maclaughlin, Joanne M Schlossin, Jogy George, John P Mistler, Jorge L Guadalupe, Jose E Melendez, DDC, Karen E D'orazio, Katherine Szestypalow, Kelli F Dobilas, Kenneth H Williams, Kent C Faul, Kevin A Gonzalez, L Gnnmassimia Massimilla, PharmD, Larry K Austin, Lata C Mathew, PhD, LCDR Michael H Tollon, Linda K Cline, Lisa K Capron, Luella J Rossi, Luis M Burgos Medero, Lydia Irosas Marty, Madushini Dharmasena, PhD, Margaret M Annes, Marianela Aponte Cruz, Marijo B Kambere, PhD, Marissa S Steinhagen, Mark R Mcclain, Matthew A Spataro, Matthew J Johnson, Michael E Maselli, Michael L Casner, Michele L Obert, Miguel A Martinez, Mindy M Chou, Mra Mcculloughj, Muralidhara B Gavini, PhD, Nadeem I Chaudhry, Nancy G Schmidt, Nataniel Phillips Sylvain, PhD, Nicholas A Violand, Nicholas L Hunt, Nicole E Knowlton, Parul M Patel, Patricia H Dlugosz, Paul E Stein, Paul Mouris, Perry T Nichols, Philip F Istafanos, DMV, MS, Phillip Angart, PhD, Rafael Nevarez Nieves, Raquel Gonzalez Rivera, Reba A Gates, Robert D Tollefsen, Robert J Maffei, Roger F Zabinski, Russell K Riley, S Lori Brown, PhD MPH, Samina S Khan, Samuel T Walker, Sarah E Mcmullen, Shelby N Turner, Simone E Pitts, Sony Mathews, Sripal R Mada, PhD, Steven M Weinman, Tamil Arasu, PhD, Thomas J Arista, Tiara Nbrown Crosen, Tracy K Li, Valentino Fiorella, Verlinda A Narcisse, Vioela J Caze, Vivin George, Vlada Matusovsky, Walden H Lee, William J Leonard, Winston R Alejo, Xing Wang, PhD, Yumi J Hiramine, Yvesna C Blaise, Zachary L Stamm, Zhongren Wu

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more